389 related articles for article (PubMed ID: 24075959)
1. Differential diagnosis of membranous nephropathy with autoantibodies to phospholipase A2 receptor 1.
Schlumberger W; Hornig N; Lange S; Probst C; Komorowski L; Fechner K; Dähnrich C; Stöcker W
Autoimmun Rev; 2014 Feb; 13(2):108-13. PubMed ID: 24075959
[TBL] [Abstract][Full Text] [Related]
2. Prediction of membranous nephropathy recurrence after transplantation by monitoring of anti-PLA2R1 (M-type phospholipase A2 receptor) autoantibodies: a case series of 15 patients.
Seitz-Polski B; Payré C; Ambrosetti D; Albano L; Cassuto-Viguier E; Berguignat M; Jeribi A; Thouret MC; Bernard G; Benzaken S; Lambeau G; Esnault VL
Nephrol Dial Transplant; 2014 Dec; 29(12):2334-42. PubMed ID: 25063424
[TBL] [Abstract][Full Text] [Related]
3. Anti-Phospholipase A2 Receptor 1 and Anti-Cysteine Rich Antibodies, Domain Recognition and Rituximab Efficacy in Membranous Nephropathy: A Prospective Cohort Study.
Ruggenenti P; Reinhard L; Ruggiero B; Perna A; Perico L; Peracchi T; Fidone D; Gennarini A; Benigni A; Cortinovis M; Hoxha E; Remuzzi G
Am J Kidney Dis; 2024 May; 83(5):588-600.e1. PubMed ID: 38151224
[TBL] [Abstract][Full Text] [Related]
4. Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy.
Dähnrich C; Komorowski L; Probst C; Seitz-Polski B; Esnault V; Wetzels JF; Hofstra JM; Hoxha E; Stahl RA; Lambeau G; Stöcker W; Schlumberger W
Clin Chim Acta; 2013 Jun; 421():213-8. PubMed ID: 23541686
[TBL] [Abstract][Full Text] [Related]
5. Multi-Autoantibody Signature and Clinical Outcome in Membranous Nephropathy.
Ghiggeri GM; Seitz-Polski B; Justino J; Zaghrini C; Payré C; Brglez V; Dolla G; Sinico A; Scolari F; Vaglio A; Prunotto M; Candiano G; Radice A; Bruschi M; Lambeau G;
Clin J Am Soc Nephrol; 2020 Dec; 15(12):1762-1776. PubMed ID: 33257410
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases.
Radice A; Pieruzzi F; Trezzi B; Ghiggeri G; Napodano P; D'Amico M; Stellato T; Brugnano R; Ravera F; Rolla D; Pesce G; Giovenzana ME; Londrino F; Cantaluppi V; Pregnolato F; Volpi A; Rombolà G; Moroni G; Ortisi G; Sinico RA
J Nephrol; 2018 Apr; 31(2):271-278. PubMed ID: 29081027
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of anti-PLA2R1 as measured by a novel ELISA in patients with idiopathic membranous nephropathy: a cohort study.
Timmermans SA; Damoiseaux JG; Heerings-Rewinkel PT; Ayalon R; Beck LH; Schlumberger W; Salant DJ; van Paassen P; Tervaert JW;
Am J Clin Pathol; 2014 Jul; 142(1):29-34. PubMed ID: 24926082
[TBL] [Abstract][Full Text] [Related]
8. Circulating antibodies to α-enolase and phospholipase A
Kimura Y; Miura N; Debiec H; Morita H; Yamada H; Banno S; Ronco P; Imai H
Clin Exp Nephrol; 2017 Feb; 21(1):117-126. PubMed ID: 26830547
[TBL] [Abstract][Full Text] [Related]
9. [Membranous nephropathy: Pathophysiology and natural history].
Seitz-Polski B; Lambeau G; Esnault V
Nephrol Ther; 2017 Apr; 13 Suppl 1():S75-S81. PubMed ID: 28577747
[TBL] [Abstract][Full Text] [Related]
10. Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN).
Radice A; Trezzi B; Maggiore U; Pregnolato F; Stellato T; Napodano P; Rolla D; Pesce G; D'Amico M; Santoro D; Londrino F; Ravera F; Ortisi G; Sinico RA
Autoimmun Rev; 2016 Feb; 15(2):146-54. PubMed ID: 26527329
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I
Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555
[TBL] [Abstract][Full Text] [Related]
12. Antigen-Specific IgG Subclasses in Primary and Malignancy-Associated Membranous Nephropathy.
von Haxthausen F; Reinhard L; Pinnschmidt HO; Rink M; Soave A; Hoxha E; Stahl RAK
Front Immunol; 2018; 9():3035. PubMed ID: 30619370
[TBL] [Abstract][Full Text] [Related]
13. The role of serum levels of anti-phospholipase A2 receptor antibodies in the diagnosis of primary membranous nephropathy.
Ronchev Y; Terzieva D; Tilkiyan E
Folia Med (Plovdiv); 2021 Oct; 63(5):692-696. PubMed ID: 35851203
[TBL] [Abstract][Full Text] [Related]
14. Anti-PLA₂R antibodies in membranous nephropathy: ready for routine clinical practice?
Hofstra JM; Wetzels JF
Neth J Med; 2012 Apr; 70(3):109-13. PubMed ID: 22516574
[TBL] [Abstract][Full Text] [Related]
15. Cross-reactivity of anti-PLA2R1 autoantibodies to rabbit and mouse PLA2R1 antigens and development of two novel ELISAs with different diagnostic performances in idiopathic membranous nephropathy.
Seitz-Polski B; Dolla G; Payré C; Tomas NM; Lochouarn M; Jeammet L; Mariat C; Krummel T; Burtey S; Courivaud C; Schlumberger W; Zorzi K; Benzaken S; Bernard G; Esnault VL; Lambeau G
Biochimie; 2015 Nov; 118():104-15. PubMed ID: 26296473
[TBL] [Abstract][Full Text] [Related]
16. Characterization of autoantibodies in primary membranous nephropathy and their clinical significance.
Stahl RA; Reinhard L; Hoxha E
Expert Rev Clin Immunol; 2019 Feb; 15(2):165-175. PubMed ID: 30433832
[No Abstract] [Full Text] [Related]
17. Clinical Relevance of Domain-Specific Phospholipase A
Reinhard L; Zahner G; Menzel S; Koch-Nolte F; Stahl RAK; Hoxha E
J Am Soc Nephrol; 2020 Jan; 31(1):197-207. PubMed ID: 31843985
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical and serological characterization of membranous nephropathy in children and adolescents.
Dettmar AK; Wiech T; Kemper MJ; Soave A; Rink M; Oh J; Stahl RAK; Hoxha E;
Pediatr Nephrol; 2018 Mar; 33(3):463-472. PubMed ID: 29034405
[TBL] [Abstract][Full Text] [Related]
19. [Update membranous nephropathy].
Hoxha E; Huber TB
Dtsch Med Wochenschr; 2020 Oct; 145(20):1481-1485. PubMed ID: 33022730
[TBL] [Abstract][Full Text] [Related]
20. A novel mouse model of phospholipase A2 receptor 1-associated membranous nephropathy mimics podocyte injury in patients.
Meyer-Schwesinger C; Tomas NM; Dehde S; Seifert L; Hermans-Borgmeyer I; Wiech T; Koch-Nolte F; Huber TB; Zahner G
Kidney Int; 2020 May; 97(5):913-919. PubMed ID: 32033781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
